Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1974 Sep;6(3):320-3.
doi: 10.1128/AAC.6.3.320.

Susceptibility of clinical isolates of bacteria to cefoxitin and cephalothin

Susceptibility of clinical isolates of bacteria to cefoxitin and cephalothin

R C Moellering Jr et al. Antimicrob Agents Chemother. 1974 Sep.

Abstract

The susceptibility of 4,929 unselected clinical isolates of bacteria to cefoxitin and cephalothin was determined by the single-disk method, using a computer-associated electronic zone analyzer to obtain, record, and process measurements of sizes of zones of inhibition. Both cefoxitin and cephalothin were effective against most gram-positive strains, including Staphylococcus aureus, S. epidermidis, micrococci, and all streptococci except enterococci. The three strains of Listeria monocytogenes tested were susceptible to cephalothin but resistant to cefoxitin. There was little difference between the cefoxitin and cephalothin susceptibility of Salmonellae, Citrobacter sp., Enterobacter sp., Proteus mirabilis, and Pseudomonas sp. Cefoxitin was more effective then cephalothin against Escherichia coli, Klebsiella sp., Serratia sp., indole-positive Proteus sp., Providence sp., Flavobacter sp., Herellea vaginicola, and Mima polymorpha. Cefoxitin also appeared to exhibit enhanced activity, as compared with cephalothin, against Bacteroides sp. Thus cefoxitin appears to have a very broad antibacterial spectrum which is greater than that of cephalothin, especially against gram-negative strains.

PubMed Disclaimer

References

    1. Am J Clin Pathol. 1966 Apr;45(4):493-6 - PubMed
    1. JAMA. 1969 Oct 6;210(1):84-92 - PubMed
    1. Appl Microbiol. 1971 Sep;22(3):476-7 - PubMed
    1. Appl Microbiol. 1972 Feb;23(2):268-75 - PubMed
    1. J Antibiot (Tokyo). 1974 Jan;27(1):42-8 - PubMed

LinkOut - more resources